Original Article
CME Article: Opioid Use Disorder among Hospitalized Adults in North Carolina: Analysis from the 2000–2020 NC State Inpatient Database
Abstract
Objectives: Opioid use disorder (OUD) is characterized as a chronic condition that was first outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, and now the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision. It encompasses frequent opioid usage, cravings, the development of tolerance, withdrawal symptoms upon discontinuation, unsuccessful attempts to quit or reduce use, and recurrent use even when faced with negative consequences. Both national- and state-level data show that overdose deaths associated with prescription opioids are increasing at an alarming rate. The increasing overdose deaths from illicitly manufactured fentanyl and other synthetic opioids compound this epidemic’s burden. The present study sought to determine the prevalence and potential factors associated with OUD in North Carolina.Methods: Using the State Inpatient Database, a retrospective cross-sectional study was conducted to identify OUD-related discharges between 2000 and 2020. Descriptive statistics and rates of OUD per 1000 discharges were calculated. Simple and multivariable logistic regression models were used to identify factors associated with increased odds of having an opioid use disorder diagnosis at discharge. The deviance-Pearson goodness of fit statistic was also used. Variables were identified using International Classification of Diseases, Ninth Revision, Clinical Modification, and International Classification of Diseases, Tenth Revision, Clinical Modification, codes in the discharge records.
Results: Of 19,370,483 hospitalizations that occurred between 2000 and 2020 in North Carolina, 483,250 were associated with OUD, a prevalence rate of 24.9 cases per 1000 discharges. The highest OUD rates were seen among adults who self-paid for their hospitalization, those with Medicaid, and those with other types of payors such as Workers’ Compensation and the Indian Health Service; individuals between 25 and 54 years old; tobacco and alcohol users; Native American patients; patients located in urban areas; patients with lower household income; White patients; and female patients. OUD also was associated with increased odds of having one or more comorbid psychiatric disorders when controlling for other factors.
Conclusions: Although preventive measures are crucial, including policies that discourage prescribing opioids for noncancer pain and those that target the manufacturing and distribution of synthetic opioids, providing integrated care for patients with OUD and co-occurring psychiatric and/or physical disorders is equally important. These findings suggest the need for a system-wide public health response focused on the expansion of primary prevention and treatment efforts, including crisis services, harm reduction services, and recovery programs.
This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Summers P, Alemu B, Quidgley-Nevares A. History of drug use predicts opioid treatment agreement violation. J Opioid Manag 2015;11:501–506.
2. Han B, Compton WM, Jones CM, et al. Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003-2013. JAMA 2015;314:1468–1478.
3. Cicero TJ, Inciardi JA, Muñoz A. Trends in abuse of OxyContin® and other opioid analgesics in the United States: 2002-2004. J Pain 2005;6:662–672.
4. Centers for Disease Control and Prevention. Drug overdose. Overview. https://www.cdc.gov/drugoverdose/deaths/prescription/overview.html. Published May 18, 2022. Accessed September 8, 2023.
5. Centers for Disease Control and Prevention. CDC Wonder: about multiple causes of death, 1999-2022. https://wonder.cdc.gov/mcd-icd10.html. Accessed September 13, 2023.
6. Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States. Results from the 2021 National Survey on Drug Use and Health. https://www.samhsa.gov/data/report/2021-nsduh-annual-national-report. Published December 2022. Accessed September 10, 2023.
7. Compton WM, Boyle M, Wargo E. Prescription opioid abuse: problems and responses. Prev Med 2015;80:5–9.
8. Centers for Disease Control and Prevention. Wide-ranging online data for epidemiologic research (WONDER). https://wonder.cdc.gov/. Accessed June 15, 2023.
9. Dowell D, Noonan RK, Houry D. Underlying factors in drug overdose deaths. JAMA 2017;318:2295–2296.
10. National Center for Health Statistics. Provisional counts of drug overdose deaths, as of 8/6/2017. https://www.cdc.gov/nchs/data/health_policy/monthly-drug-overdosedeath-estimates.pdf. Accessed June 16, 2023.
11. Wilson N, Kariisa M, Seth P, et al. Drug and opioid-involved overdose deaths —United States, 2017–2018. MMWR Morb Mortal Wkly Rep 2020;69: 290–297.
12. The Blanchard Institute. North Carolina alcohol abuse statistics. https://theblanchardinstitute.com/drug-alcohol-abuse/. Accessed May 29, 2023.
13. National Center for Substance Abuse and Addiction Statistics. Drug abuse statistics. https://drugabusestatistics.org/. Accessed September 15, 2022.
14. North Carolina Department of Health and Human Services. Overdose epidemic. Combating North Carolina’s opioid crisis. https://www.ncdhhs.gov/about/department-initiatives/overdose-epidemic. Accessed June 9, 2023.
15. National Institute of Drug Abuse. North Carolina opioid summary. https://nida.nih.gov/drug-topics/opioids/opioid-summaries-by-state/north-carolina-opioid-involved-deaths-related-harms. Accessed June 2, 2023.
16. Centers for Disease Control and Prevention. CDC Wonder: about multiple cause of death, 2018-2021, single race. https://wonder.cdc.gov/mcd-icd10-expanded.html. Accessed September 13, 2023.
17. North Carolina Department of Health and Human Services. Opioid and substance use action plan data dashboard. https://www.ncdhhs.gov/opioid-and-substance-use-action-plan-data-dashboard. Accessed September 13, 2023.
18. Centers for Disease Control and Prevention. State Unintentional Drug Overdose Reporting System (SUDORS), final data. https://www.cdc.gov/drugoverdose/fatal/sudors.html. Accessed September 13, 2023.
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2022.
20. Haight SC, Ko JY, Tong VT, et al. Opioid use disorder documented at delivery hospitalization—United States, 1999–2014. MMWR Morb Mortal Wkly Rep 2018;67:845–849.
21. Lister JJ, Weaver A, Ellis JD, et al. A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States. Am J Drug Alcohol Abuse 2020;46:273–288.
22. Florence C, Luo F, Rice K. The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017. Drug Alcohol Depend 2021; 218:108350.
23. Agency for Healthcare Research and Quality. Introduction to the HCUP State Inpatient Databases (SID). https://hcup-us.ahrq.gov/db/state/siddist/SID_Introduction.jsp. Accessed June 5, 2023.
24. Healthcare Cost and Utilization Project. HCUP user support. https://hcup-us.ahrq.gov/. Accessed August 15, 2023.
25. Ghertner R. US county prevalence of retail prescription opioid sales and opioid-related hospitalizations from 2011 to 2014. Drug Alcohol Depend 2019;194:330–335.
26. Fujihara N, Fujihara Y, Sterbenz JM, et al. Impact of economic downturn on the surgical volumes of common hand procedures. Plast Reconstr Surg 2019;143:340e–349e.
27. Manzano-Nunez R, Zogg CK, Bhulani N, et al. Association of Medicaid expansion policy with outcomes in homeless patients requiring emergency general surgery. World J Surg 2019;43:1483–1489.
28. Healthcare Cost and Utilization Project. Clinical Classifications Software. https://hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp. Accessed June 11, 2023.
29. Sebastiao YV, Metzger GA, Chisolm DJ, et al. Impact of ICD-9-CM to ICD10-CM coding transition on trauma hospitalization trends among young adults in 12 states. Inj Epidemiol 2021;8:4.
30. North Carolina Department of Health and Human Services. Overdose epidemic. https://www.ncdhhs.gov/about/department-initiatives/overdose-epidemic. Accessed September 9, 2022.
31. Montiel Ishino FA, McNab PR, Gilreath T, et al. A comprehensive multivariate model of biopsychosocial factors associated with opioid misuse and use disorder in a 2017–2018 United States national survey. BMC Public Health 2020;20:1–6.
32. Andersson HW, Mosti MP, Nordfjaern T. Inpatients in substance use treatment with co-occurring psychiatric disorders: a prospective cohort study of characteristics and relapse predictors. BMC Psychiatry 2023;23:152.
33. McHugh RK, Votaw VR, Sugarman DE, et al. Sex and gender differences in substance use disorders. Clin Psychol Rev 2018;66:12–23.
34. Siddiqui N, Urman RD. Opioid use disorder and racial/ethnic health disparities: prevention and management. Curr Pain Headache Rep 2022; 26:129–137.
35. Lippold KM, Jones CM, Olsen EOM, et al. Racial/ethnic and age group differences in opioid and synthetic opioid–involved overdose deaths among adults aged ≥18 years in metropolitan areas—United States, 2015–2017. MMWR Morb Mortal Wkly Rep 2019;68:967.
36. National Institute on Drug Abuse. Disparities in opioid overdose deaths continue to worsen for Black people, study suggests. https://archives.nida.nih.gov/news-events/news-releases/2021/09/disparities-in-opioid-overdose-deaths-continue-to-worsen-for-black-people-study-suggests. Accessed July 5, 2023.
37. North Carolina Department of Health and Human Services. NCDHHS continues fight against overdose epidemic. https://www.ncdhhs.gov/about/department-initiatives/overdose-epidemic. Accessed June 16, 2023.
38. Rajbhandari-Thapa J, Zhang D, Padilla HM, et al. Opioid-related hospitalization and its association with chronic diseases: findings from the National Inpatient Sample, 2011–2015. Prev Chronic Dis 2019;16:E157.
39. Cordes J. Spatial trends in opioid overdose mortality in North Carolina: 1999–2015. Southeast Geogr 2018;58:193–211.
40. Martins SS, Keyes KM, Storr CL, et al. Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend 2009;103:16–24.
41. Rosic T, Naji L, Bawor M, et al. The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study. Neuropsychiatr Dis Treat 2017;13:1399–1408.
42. Levis SC, Mahler SV, Baram TZ. The developmental origins of opioid use disorder and its comorbidities. Front Hum Neurosci 2021;15:601905.
43. Krantz MJ, Palmer RB, Haigney MCP. Cardiovascular complications of opioid use. JACC 2021;77:205–223.
44. O’Malley KJ, Cook KF, Price MD, et al. Measuring diagnoses: ICD code accuracy. Health Serv Res 2005;40:1620–1639.
